Analysed TRANSCODE THERAPEUTICS INC (RNAZ:NASDAQ) News Sources
TransCode Therapeutics Enters into Agreements for up to $20 Million Flexible Financing, Extending Company's Runway into Late 2027/Early 2028
07-04-2026
yahoo.com
CK Life Sciences Establishes Sequencio Therapeutics to Advance Therapeutic Cancer Vaccines Development
10-03-2026
yahoo.com
TransCode Secures Exclusive, Worldwide, Fully Paid-Up Royalty-Free License to Develop and Commercialize a Next-Generation Oncolytic Immunotherapy Platform in an All-Stock Transaction Underscoring the Company's Dedication to Improving the Lives of Cancer Patients
03-03-2026
yahoo.com
TransCode Therapeutics Announces Publication of Preclinical Testing of RIG-I Immunotherapeutic Candidate Supporting Further Development
23-02-2026
yahoo.com
TransCode Therapeutics and Quantum Leap Announce Submission of IND Amendment for Phase 2a Clinical Trial with TTX-MC138
05-02-2026
yahoo.com
TransCode Therapeutics Announces Publication of Preclinical Data Supporting Therapeutic Potential of TTX-MC138 in Glioblastoma
06-01-2026
yahoo.com
TransCode Therapeutics Expands Leadership with Appointment of Jack E. Stover to Board of Directors
22-12-2025
yahoo.com
TransCode Therapeutics and Quantum Leap Healthcare Collaborative Launch a Phase 2a dose-expansion trial with TTX-MC138, following positive readouts from TransCode's Phase 1 trial
11-12-2025
yahoo.com
TransCode Therapeutics Expands Executive Team with Appointment of Dr. Michel Janicot as Senior Development Officer
17-11-2025
yahoo.com
What is the current price of TRANSCODE THERAPEUTICS INC (RNAZ:NASDAQ)?
The current price of TRANSCODE THERAPEUTICS INC (RNAZ:NASDAQ) is $8.21.
TRANSCODE THERAPEUTICS INC (RNAZ:NASDAQ) absolute price change since previous trading day?
The absolute price change of TRANSCODE THERAPEUTICS INC (RNAZ:NASDAQ) since the previous trading day is $-0.34.
TRANSCODE THERAPEUTICS INC (RNAZ:NASDAQ) percentage price change since previous trading day?
The percentage price change of TRANSCODE THERAPEUTICS INC (RNAZ:NASDAQ) since the previous trading day is -3.9766%.
What is the most recent average sentiment score for TRANSCODE THERAPEUTICS INC (RNAZ:NASDAQ)?
The most recent average sentiment score for TRANSCODE THERAPEUTICS INC (RNAZ:NASDAQ) is 80 out of 100.
What is the most recent average sentiment for TRANSCODE THERAPEUTICS INC (RNAZ:NASDAQ)?
The most recent sentiment for TRANSCODE THERAPEUTICS INC (RNAZ:NASDAQ) is .
SEC-8K** Filing Available For TRANSCODE THERAPEUTICS INC (RNAZ:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.